Fig. 6

NIR-II activated BPSP robust antitumor efficacy in orthotopic HCC models. a Schematic in orthotopic HCC models. b Bioluminescence images of tumor-bearing mice in different groups during treatment. c Bioluminescence intensity curves of tumor-bearing mice. d Bioluminescence intensity curves of tumor-bearing mice in A area. e Representative photographs and H&E results of the liver with each group. Data represented mean ± SD (n = 3). **p < 0.01, in contrast to the NS group. ^##p < 0.01, ^#p < 0.0, in contrast to BPSP + L group